Achieve Life Sciences, Inc. SEC filings ACHV
Achieve Life Sciences, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Apr 15, 2009. Its latest annual report, Form ARS, was filed on Jun 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 14, 2026 | — |
| S-8 | Employee stock plan registration | May 12, 2026 | — |
| S-3 | Shelf registration | May 12, 2026 | — |
| S-8 | Employee stock plan registration | Apr 16, 2026 | — |
| S-8 | Employee stock plan registration | Mar 24, 2026 | — |
| S-3 | Shelf registration | Jan 23, 2026 | — |
| 424B5 | Prospectus supplement | Jun 27, 2025 | — |
| 424B5 | Prospectus supplement | Jun 26, 2025 | — |
| S-8 | Employee stock plan registration | Jan 10, 2025 | — |
| S-8 | Employee stock plan registration | Dec 5, 2024 | — |
| S-3 | Shelf registration | Nov 7, 2024 | — |
| POS AM | Filing | Nov 7, 2024 | — |
| 424B5 | Prospectus supplement | Sep 27, 2024 | — |
| S-3 | Shelf registration | Jun 28, 2024 | — |
| S-3 | Shelf registration | Apr 26, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| S-3 | Shelf registration | Jun 14, 2023 | — |
| 424B5 | Prospectus supplement | May 25, 2023 | — |
| S-8 | Employee stock plan registration | Mar 16, 2023 | — |
| 424B7 | Filing | Jan 12, 2023 | — |
| S-3/A | Filing | Jan 3, 2023 | — |
| S-3 | Shelf registration | Dec 29, 2022 | — |
| S-8 | Employee stock plan registration | Mar 10, 2022 | — |
| S-3 | Shelf registration | Dec 21, 2021 | — |
| 424B5 | Prospectus supplement | May 25, 2021 | — |
| 424B5 | Prospectus supplement | May 24, 2021 | — |
| S-8 | Employee stock plan registration | Mar 11, 2021 | — |
| 424B4 | Prospectus | Dec 4, 2020 | — |
| S-1MEF | Filing | Dec 2, 2020 | — |
| FWP | Free writing prospectus | Nov 30, 2020 | — |
| S-1/A | Amended registration statement | Nov 30, 2020 | — |
| S-1 | Registration statement | Nov 13, 2020 | — |
| 424B5 | Prospectus supplement | Aug 4, 2020 | — |
| 424B5 | Prospectus supplement | Aug 3, 2020 | — |
| 424B5 | Prospectus supplement | Jun 29, 2020 | — |
| S-1 | Registration statement | Jun 5, 2020 | — |
| S-8 | Employee stock plan registration | May 19, 2020 | — |
| S-8 | Employee stock plan registration | Jan 24, 2020 | — |
| 424B4 | Prospectus | Dec 18, 2019 | — |
| S-1/A | Amended registration statement | Dec 16, 2019 | — |
| FWP | Free writing prospectus | Dec 2, 2019 | — |
| S-1/A | Amended registration statement | Dec 2, 2019 | — |
| S-1 | Registration statement | Nov 6, 2019 | — |
| S-1/A | Amended registration statement | Aug 2, 2019 | — |
| S-1 | Registration statement | Jul 25, 2019 | — |
| 424B5 | Prospectus supplement | Jun 7, 2019 | — |
| 424B5 | Prospectus supplement | May 15, 2019 | — |
| S-8 | Employee stock plan registration | May 15, 2019 | — |
| S-3 | Shelf registration | Dec 26, 2018 | — |
| S-1 | Registration statement | Nov 29, 2018 | — |
| S-8 | Employee stock plan registration | Nov 7, 2018 | — |
| 424B5 | Prospectus supplement | Oct 1, 2018 | — |
| 424B4 | Prospectus | Jun 15, 2018 | — |
| S-1MEF | Filing | Jun 14, 2018 | — |
| S-1/A | Amended registration statement | Jun 13, 2018 | — |
| S-1/A | Amended registration statement | Jun 12, 2018 | — |
| FWP | Free writing prospectus | Jun 6, 2018 | — |
| S-1/A | Amended registration statement | Jun 6, 2018 | — |
| S-1 | Registration statement | May 10, 2018 | — |
| S-8 | Employee stock plan registration | Nov 9, 2017 | — |
| 424B5 | Prospectus supplement | Sep 14, 2017 | — |
| 424B3 | Prospectus | Jun 13, 2017 | — |
| S-4/A | Filing | Jun 6, 2017 | — |
| S-4/A | Filing | May 24, 2017 | — |
| S-4/A | Filing | May 3, 2017 | — |
| S-4 | Registration for a merger or exchange | Mar 27, 2017 | — |
| S-3 | Shelf registration | Oct 29, 2015 | — |
| S-8 | Employee stock plan registration | Aug 25, 2015 | — |
| 424B5 | Prospectus supplement | Apr 30, 2015 | — |
| S-8 | Employee stock plan registration | Aug 7, 2014 | — |
| 424B5 | Prospectus supplement | Jun 27, 2014 | — |
| FWP | Free writing prospectus | Jun 26, 2014 | — |
| S-8 | Employee stock plan registration | Aug 8, 2013 | — |
| 424B5 | Prospectus supplement | Jun 18, 2013 | — |
| S-3 | Shelf registration | Nov 8, 2012 | — |
| 424B5 | Prospectus supplement | Mar 16, 2012 | — |
| 424B5 | Prospectus supplement | Mar 15, 2012 | — |
| S-3 | Shelf registration | Nov 3, 2011 | — |
| POS AM | Post effective amendment no. 1 to form s-3 | Dec 3, 2010 | — |
| 424B5 | Prospectus supplement | Oct 19, 2010 | — |
| 424B3 | Prospectus | Oct 18, 2010 | — |
| S-8 | Employee stock plan registration | Aug 13, 2010 | — |
| 424B5 | Prospectus supplement | Jul 20, 2009 | — |
| S-3/A | Amendment no. 1 to form s-3 | Jul 13, 2009 | — |
| S-3 | Shelf registration | Jun 26, 2009 | — |
Showing 86 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- ACHV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Seattle, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 949858
- Former names
- ONCOGENEX PHARMACEUTICALS, INC. (until Jul 31, 2017); SONUS PHARMACEUTICALS INC (until Aug 7, 2008)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.